Form D · Other Health Care
Mimosa Therapeutics, A Public Benefit Corp
Alameda, CA · CIK 0001844977
Offering snapshot reported Jul 14, 2021 · SEC filing
- Reported sold
- $400K Offering amount: $400K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2021 | Initial | $399,980 | No comparison | Not reported | SEC filing |
| Feb 10, 2021 | Initial | $864,999 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-406183
Source: Form D, filed Jul 14, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Apkon | Director |
| Amanda Feilding | Director |
| James Keim | Director, Executive, Promoter |
| Robert Stanley | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
780 Taylor Avenue, Apt. A
Alameda, CA, 94501
Alameda, CA, 94501